טוען...
Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens
The recent development in immune checkpoint inhibitors and chimeric antigen receptor (CAR) T‐cells in the treatment of cancer has not only demonstrated the potency of utilizing T‐cell reactivity for cancer therapy, but has also highlighted the need for developing new approaches to discover targets s...
שמור ב:
| הוצא לאור ב: | Proteomics |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032843/ https://ncbi.nlm.nih.gov/pubmed/29786170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pmic.201700465 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|